Haemosatasis 1 Flashcards
(42 cards)
What are the two potential outcomes of the haemostatic system
May stop you bleeding to death.
May kill you with thrombosis
What is the ultimate aim of clinical haemostasis
A balance between thrombosis and bleeding
What happens in an intact blood vessel
coagulation factors (denoted by roman numerals) help form plug, regulatory proteins stop premature firing to prevent thrombosis
Describe the platelets
fragments of cells made from megakaryocytes in bone marrow, containing granules and receptors
Where are the triggers for coagulation found though
Found outside the circulation- expressed on fibroblasts (collagen and tissue factors).
What is separated at rest in haemostasis
factors and cofactors separated
What is the von Wileband Factor
VWF is a giant adhesive plasma protein
with many binding sites for platelets (GP1b, GP2b3a), collagen, factor VIII; assembled to multimers (20-50 monomers); usually rolled up in blood so binding sites hidden
Biggest soluble protein in the blood.
Describe what the von Willeband Factor does in response to shear stress
The collagen binding sites are normally hidden- but the shear stress of blood stretches collagen and when it binds to collagen- it becomes long and thin-exposing binding sites
Must be bound to collagen first
Bumps and gaps represent monomer
Describe the key features of platelet structure
Adhesive receptors on surface can bind to vWF (GP1b complex/Integrin alpha-II-b-beta3) and collagen (P1a-Iia/GPVI complex)
Stimulatory receptors on surface can be activated by ADP (purine receptors e.g. P2Y1/12), thromboxane and PGI2
What can stimulate platelet activation
ADP, Thromboxane and PGI2.
Describe the histology of platelets
Much smaller than erythrocytes
Granular (ADP, fibrinogen, vWF).
What granules are present inside the platelet
Lysosome
Alpha granule
Dense granule
Describe the formation of the platelet plug
Endothelium damaged Blood meets collagen and tissue factor VWF in rolled up form VWF binds to collagen- stretched out Binding sites exposed for platelets Platelet Activation Degranulation- more VWF- more platelets trapped Fibrinogen links the platelets together Formation of primary platelet plug Coagulation system not used.
What is not required for primary haemostasis
Tissue factor
What happens in platelet activation
Conversion from a passive to an interactive cell
Activated platelets:
Change shape
Expose phospholipid- negatively charged phospholipid.
Present new or activated proteins on their surface (i.e. GpIIb/IIIa)
What can cause platelets to change shape
Shape changes during adhesion, activation and aggregation
What happens when platelets bind to the VWF
Platelets bind to VWF via GpIb
This slows down the platelet- allowing it to bind to collagen via Gp I- II alpha or the GPV1 complex. Platelets link together via fibrinogen via GPIIB-IIIa.
This binding activates the platelet and signals the activation of the platelet:
Dense granules release ADP
Alpha granules release Fibrinogen and VWF
Phospholipid exposed- TXA2 produced- which can act on the platelet
Brought about by Ca2+ influx.
What does primary haemostasis require
Requires
Collagen
Platelets
Von Willebrand Factor
Where is primary haemostasis sufficient
Sufficient for small vessels
In larger vessels requires stabilisation (fibrin)
How do we stabilise the plug formed in primary haemostasis
Coagulation:
Formation of a fibrin mesh
(secondary haemostasis)
Where are Clotting Factors, Fibrinolytic
Factors and Inhibitors synthesised
- The liver
- Endothelial cells (VIII and VWF)
- Megakaryocytes ( differentiate to platelets) (VWF ± FV)
Most synthesis is in the liver
What does ‘a’ mean after VIIa
Activated
Circulates in its active form- but useless until it meets its cofactor (tissue factor).
Describe secondary haemostasis
Endothelium damaged
Blood meets collagen and tissue factors (normally outside the vessel)
In 2o haemostasis, collagen not important, factor VIIa (activated factor VII - circulates in active form; useless unless tissue factor co-factor present) binds to co-factor
Tissue factor-VIIa complex forms, converting inactive FIX/FX zymogens to activated FIXa/Fxa
TFPI (Tissue factor pathway inhibitor) binds to FXa, FVIIa, and TF to sequester in inactive form to dampen and stop pathway as soon as begins
If large enough stimulus, FXa converts FII to thrombin
Thrombin forms FV and FVIII- which are cofactors for FXa and FIXa respectively- Ca2+, PL, FIXa, FVIIIa] which converts FX to FXa, and [Ca2+, PL, FXa, FVa] which converts FII to thrombin
What is thrombin
Thrombin cleaves fibrinogen (soluble and bulk) to fibrin (insoluble and forms mesh)